life is greatly reduced in these subjects [2] , owing in particular to autonomic [3] and peripheral neuropathy.
Introduction
trate into the perineurium. Before the injection and 1-6 days later we evaluated maximun conduction Nervous system malfunction easily develops in patients velocity (MCV ) and compound muscle action potenwith chronic renal failure (CRF ) [1] . The quality of tial (CMAP) amplitude and/or temporal dispersion. The effect of uraemic concentrate on the amplitude of Correspondence and offprint requests to: Dr Salvatore Cantaro, the nervous signal evoked by a maximal electrical Patients proximal or distal stimulation. After the initial recordings of the neurophysiological parameters, 30 ml of uraemic concenTwo female patients (age 87 and 71), showing uraemic trate, aseptically dissolved in saline at 6 mg of proteins/ml, neuropathy at clinical and EMG examination and selected were injected into the perineurium approximately midway for PFD owing to cardiovascular instability during standard between the proximal and distal stimulation sites. Control dialysis, were chosen to obtain the uraemic concentrate. The recordings were made to exclude the presence of traumatic patients were not treated with drugs with MW>l kDa or lesion of the nervous trunk. In cases of nerve lesion due to drugs with high protein binding for at least 1 week before the injection, the rat was discarded and replaced. the ultrafiltrate sampling.
The same surgical and electrophysiological procedure was carried out on the right sciatic nerve, using human albumin (6 mg/ml in saline) as control.
Uraemic concentrate
In six rats which had undergone successful surgery and in good health, the left and right sciatic nerves were again About 5 litres of PFD ultrafiltrate from each patient were surgically exposed 1-6 days after the initial injection and the aseptically 1000-fold concentrated in an Amicon stirred electrophysiological evaluation was repeated. chamber using a semi-permeable membrane with 2-kDa MW cut-off (Amicon UM-2) at +4°C. The resulting concentrate was dialysed overnight against sterile distilled water using benzoylated dialysis tubing, filtered through a 0.2-mm sterilizIn vitro study ing filter, freeze-dried and stored at −20°C until use.
Frogs of either sex, weighing between 100 and 140 g, were
In vivo intraneural injection stunned, decapitated and pithed. Sciatic nerves were dissected from the spinal cord to the knee, desheathed under a Six rats, weighing about 350 g, were anaesthetized by inhala-dissecting stereoscope, and placed in a three-chambered bath tion of saturated isoflurane (ForaneB); immediately there- [11, 12] for electrophysiological evaluation of their viability. after, 1.5 ml of thiopental solution (Pentothal sodium The bath consists of a middle chamber, the perfusion cham-0.025%) was injected endoperitoneally to hold anaesthesia ber (25×25×9 mm, total volume 5.5 cm3), and of two and a second 0.5-ml thiopental injection was given after smaller compartments, the stimulating chamber and the 60 min. From the beginning of the surgery and throughout recording chamber, each located at one side of the perfusion the experiment, the rectal temperature was maintained chamber; the chambers were separated by a thick layer of between 37 and 38.5°C by an infrared heating lamp, with silicone-based elastomeric impression material of low viscoscontinuous monitoring.
ity ( Xanthopren, Bayer Dental ). The nerve was left floating With the rat in the prone position, the left thigh was across the three chambers in oxygenated (100% O 2 ) saline, shaved and a skin incision of about 2.5 cm was cut on a with the following composition (in mM ): 111 NaCl, horizontal plane beyond the left iliac ridge. The sciatic nerve 2.41 KCl, 10 HEPES, 2 CaCl 2 , 10 glucose, pH 7.4 at was exposed by blunt dissection from the ischial foramen to 22±0.5°C. the muscular thigh branches and the main sciatic trunk was
The amplitude of the evoked maximum compound action isolated by external neurolysis together with its muscular potential (MCAP) was used as index of the viability of the branches, preserving the vascular contribution. The injection nerve. Silver wire 0.5-mm stimulating electrodes were placed site was chosen along the main sciatic trunk, about 1 cm in the stimulating chamber where the proximal end of the from the ischial foramen. In case where the sciatic nerve nerve was floating. A constant-voltage stimulator providing came through the foramen with its muscular branches, the monophasic 0.02-ms pulses of 2.5-5 V at a continuous injection point was located at the same distance on the larger frequency of 1 Hz was connected to the stimulating electrode. nerve branch. The uraemic concentrate was injected into the To ensure that all axons were stimulated, the intensity of the perineurium with a 31-gauge needle, using a stereoscope to stimuli was adjusted to approximately twice the voltage avoid nerve damage and to verify the condition of the required to induce the compound spike of maximal ampliperineurium after needle removal. The skin was finally closed tude. Silver wires were also used as recording electrodes in with a continuous suture. the recording chamber. The potentials recorded from the distal end of the nerve were amplified using a Neurolog NL108 amplifier and filtered with a bandwidth of 10 kHz.
In vivo electrophysiological examination
The output signal of the amplifier was connected to a digitizing oscilloscope fitted with IEEE-488 interface circuitry A stainless-steel needle stimulating electrode was positioned allowing transfer of records to a personal computer. Custom adjacent to the sciatic nerve near the sciatic notch for software was written to completely automate the insertion proximal stimulation, or exactly 2 cm from the proximal of control signals, the sampling of wave shape, the storage stimulation point, near the ankle, for distal stimulation; a of the data, and their analysis. ground electrode was placed between the stimulating and The nerves were exposed to three different concentrations recording electrodes. Square-wave pulses of 0.2 ms were used of the uraemic concentrate (0.1, 0.16 and 0.33 mg/ml ); as stimuli, and their intensity was increased until the comcontrol experiments were performed using human albumin pound muscle action potential (CMAP) amplitude recorded (0.33 mg/dl ). In all valid experiments, run for about 35 h, in the foot muscles was maximal. CMAPs were recorded the MCAP at the start of the stimulation had a value between from the intrinsic foot muscles using a stainless-steel needle 12 and 16 mV. After the end of each experiment, all MCAF electrode with the tip penetrating the skin of the dorsal amplitudes were measured and the percentage amplitude surface of the foot.
Neurophysiological parameters used to detect the neuro-against time was plotted, assuming 100% as the starting value. Figure 1 ). Uraemic concentrate Results injection also decreased MCV ( Table 1) , but its reduction was less sensitive than CMAP's reduction, being Table 1 summarizes the results of in vivo experiments. present after 5 days. The uraemic concentrate injected in the six nerves
The in vitro results of our study confim the presence induced a neurotoxic effect, revealed by the proof a neurotoxic substance in the concentrate from gressive decline of electrophysiological parameters. In uraemic plasma. In fact the nerves exposed to the contralateral control nerves the electrophysiological uraemic concentrate ( Figure 2B ) reveal a progressive evaluation showed instead minor changes either in decline in MCAP amplitude, indicating the presence CMAP amplitude (±15%) or temporal dispersion and of nervous damage. In contrast, in control sciatic in VCM (±20%).
nerves MCAP does not show any change up to 35 h As shown in Figure 1 , proximal and distal CMAP ( Figure 2A ), a demonstration that the nerve viability temporal dispersion produced the most sensitive elecis not affected by the recording conditions. The curves trophysiological parameter to reveal the impairment shown in Figure 1B allow calculation of the time of nerves injected with uraemic concentrate, because required to reduce the amplitude of the MCAP to 50 its deterioration begins from the second day after the or 75% of its control value, according to the concentrainjection, reaching the maximum after 6 days. Also tion of the uraemic concentrate; this time is called CMAP amplitude showed a sensitivity comparable to effective time ( ET ) 50% or 75%. The values of ET CMAP temporal dispersion as an index of nervous 50% and ET 75% for the control nerves and for the damage, since its reduction begins on the second day after the injection, and declines with time to a very nerves exposed to uraemic concentrate are shown in 
Discussion
Uraemic neuropathy is a distal, symmetrical, mixed neuropathy. In particular neurotoxic compounds may, polyneuropathy that is present in the majority of for example, inhibit in the axons the enzymes required patients with end-stage renal disease being treated by for energy synthesis or may interfere with the axonal dialysis. Many types of toxic compounds can cause transportation and with the enzyme replacement from central-peripheral axonopathies, inducing almost neuronal soma, thus leading to a block of energyidentical clinical patterns of distal, symmetrical poly-dependent axonal currents and therefore in distal fibre degeneration [13] . The identification of potential neurotoxic com- account that an improvement in MCV is consistent only after renal transplantation [18, 19] , although a ET 50% or ET 75%: effective time (h) required to reduce the slight improvement can also be found after the beginamplitude of the MCAP to 50 or 75% of its control value (mean of three experiments).
ning of dialysis treatment. Therefore the neurotoxin possibly responsible for the uraemic neuropathy could
In
the uraemic neuropathy, even if the use of highplanted kidney.
permeability polysulphone membranes could increase To obtain a sample of middle molecules present in the removal of the middle molecule(s) and improve uraemic plasma, we concentrated the plasma ultrathe course of uraemic neuropathy, as reported by filtrate generated in PFD, a renal replacement therapy Malberti and colleagues [27] . in which the ultrafiltration of plasma precedes the As for the identity of the neurotoxic compound, our diffusive dialysis. The ultrafiltrate obtained consists of experiment can rule out low-MW compounds, such as the plasma fractions of MW<60, that filter through myoinositol, creatinine, or urea as causal factors of high-permeability PFD membranes but that do not neuropathy. Within higher-MW compounds, PTH permeate the standard cuprophane filters, while the (9424 MW ) has been proposed in the pathogenesis of lower-molecular-weight compounds (<2 kDa) such as uraemic neuropathy, for its possible role in the accumuurea or creatinine are excluded: in fact, the uraemic lation of calcium in the nerves and consequent slower concentrate was found to consist mainly of proteic rise of action potential at the nodes of Ranvier [16 ] . substances. To test this compound as a possible neuroHowever, PTH has no detectable effect on peripheral toxin two different approaches were selected: the in nerve function in primary hyperparathyroidism [28] , vivo electrophysiological study after intraneural injecand this observation is sufficient to rule out this tion of the molecules and the in vitro neurotoxicological calciotropic hormone as possible cause of uraemic study in the isolated nerve. Given the impossibility of neuropathy. From the data of our study we cannot obtaining a PFD ultrafitrate from healthy subjects,
give conclusive results about the identification of the human albumin was used in control experiments as substance responsible for the pathogenesis of uraemic the best compromise to mimic a possible granulomatneuropathy, and further studies based on the separaous or inflammatory response at the injection site.
tion and characterization of the mean molecule are Intraneural injection in experimental animals has needed. been widely used to test the pathogenetic activity of
To define histologically the type of damage of various substances, among which are patient's sera uraemic neuropathy, Dinn and Crane [29] found a [20] . This technique allows testing of the neurotoxicity segmental demyelination, ranging from widening of of a substance in an almost physiological condition, the nodes of Ranvier to partial or complete loss of taking also into account the effect of the fluid movemyelin of internodal segments; in contrast, Dyck et al. ment within the perineurium and between the nerve [30] reported a fibre degeneration with shrinkage of fibres. In the in vitro approach, the isolated sciatic the axis cylinders (axonal degeneration) and secondary nerve, with stimulating electrodes attached at one end demyelination. Our electrophysiological data are conand recording electrodes at the other end, has been a sistent with the presence of prevalent myelinic damage standard preparation for various neuropharmacologas the electrophysiological correlates of the demyical studies such as the effect of local anaesthetics elination are present: (i) an important reduction in [21,22], ionizing and non-ionizing radiations [23, 24] , MCV (while in axonopathies MCV is only moderately and pyrethroid insecticides [9, 25] . Furthermore, a reduced ), and (ii) a significant increase in CMAP similar three-chambered bath has also been used duration coupled with a decrease of its amplitude, due extensively to study axoplasmic transportation [26 ] .
to irregular impairment in the progression of action Our results, obtained by two different experimental potentials between Ranvier's nodes; consequently the approaches, demonstrate that the plasma ultrafiltrate nerve action potentials reach the muscle fibres asynof uraemic patients contains a substance of MW chronously, increasing the duration of muscle contracbetween 2 and 60 kDa that is poorly dialysed and tion at EMG and decreasing its maximum voltage. exhibits a neurotoxic effect. Since from 5 litres of PFD The electrophysiological abnormalities are not limultrafiltrate about 12 mg of dry compound is obtained, ited to the injection area, but CMAP amplitude, its concentration in PDF ultrafiltrate is about 2.5 mg/l; CMAP temporal dispersion, and MCV are also found taking also into account a minimum neurotoxic con-to be altered in distal stimulation, giving the rationale centration of 200 mg/l ( Table 2), the total plasma mass to hypothesize that the extension of the damage is of the neurotoxic compound should be at least 8 g. downwards of the injection segment, probably due to Consequently, to obtain a 50% reduction of the neuro-the diffusion of uraemic concentrate within the perineutoxin in a patient's plasma during a single PFD session rium of the sciatic nerve; conversely one can conceive would require a huge 1600-litre ultrafiltrate.
an interference with intra-axonal transport of nutrients. Finally, we are aware of the problem that proper Finally, our data suggest that the diffusion of highcontrol experiments using ultrafiltrate from non-permeability membranes could contribute to a decrease uraemic individuals had not been performed. This was in the number of uraemic patients presenting neurodue to the fact that the necessary amounts of ultrafil-pathy and contribute in the future to the eradication trate could not be obtained from volunteers because of this invalidating complication of uraemia. of ethical considerations. Unfortunately, ultrafiltrate from large animals is not available to us for technical Acknowledgements. We are indebted to Dr Agostino Naso, Division of Nephrology 2, Padova, for obtaining PDF ultrafiltrate.
reasons.
